A simple and reproducible prognostic index in luminal ER-positive breast cancers

Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093 Varga, 2012, How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists, PLoSOne, 7, e37379, 10.1371/journal.pone.0037379 Longacre, 2006, Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study, Mod Pathol, 19, 195, 10.1038/modpathol.3800496 Dalton, 1994, Histologic grading of breast carcinoma. A reproducibility study, Cancer, 73, 2765, 10.1002/1097-0142(19940601)73:11<2765::AID-CNCR2820731119>3.0.CO;2-K Tsuda, 2010, HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens, BMC Cancer, 10, 534, 10.1186/1471-2407-10-534 Haybittle, 1982, A prognostic index in primary breast cancer, Br J Cancer, 45, 361, 10.1038/bjc.1982.62 Galea, 1992, The Nottingham Prognostic Index in primary breast cancer, Breast Cancer Res Treat, 22, 207, 10.1007/BF01840834 Blamey, 2007, Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999, Eur J Cancer, 43, 1548, 10.1016/j.ejca.2007.01.016 Lee, 2008, The Nottingham prognostic index for invasive carcinoma of the breast, Pathol Oncol Res, 14, 113, 10.1007/s12253-008-9067-3 Ravdin, 2001, Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer, J Clin Oncol, 19, 980, 10.1200/JCO.2001.19.4.980 Hajage, 2011, External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement, PLoS One, 6, e27446, 10.1371/journal.pone.0027446 Castellano, 2010, Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers, Breast Cancer Res Treat, 124, 607, 10.1007/s10549-010-0761-y Hickey, 2012, Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?, Mol Endocrinol, 26, 1252, 10.1210/me.2012-1107 Sapino, 2006, Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure, Virchows Arch, 449, 288, 10.1007/s00428-006-0233-2 Fisher, 1969, Cancer of the breast: size of neoplasm and prognosis, Cancer, 24, 1071, 10.1002/1097-0142(196911)24:5<1071::AID-CNCR2820240533>3.0.CO;2-H Carter, 1989, Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases, Cancer, 63, 181, 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H Arisio, 2000, What modifies the relation between tumour size and lymph node metastases in T1 breast carcinomas?, J Clin Pathol, 53, 846, 10.1136/jcp.53.11.846 O'Reilly, 1990, Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry, J Clin Oncol, 8, 2040, 10.1200/JCO.1990.8.12.2040 Duffy, 2006, Tumor size and breast cancer detection: what might be the effect of a less sensitive screening tool than mammography?, Breast J, 12, S91, 10.1111/j.1075-122X.2006.00207.x Verschraegen, 2005, Modeling the effect of tumor size in early breast cancer, Ann Surg, 241, 309, 10.1097/01.sla.0000150245.45558.a9 Goldhirsch, 2011, Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011, Ann Oncol, 22, 1736, 10.1093/annonc/mdr304 Peters, 2009, Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer, Cancer Res, 69, 6131, 10.1158/0008-5472.CAN-09-0452 Park, 2011, Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers, Ann Oncol, 22, 1755, 10.1093/annonc/mdq678 Hu, 2011, Androgen receptor expression and breast cancer survival in postmenopausal women, Clin Cancer Res, 17, 1867, 10.1158/1078-0432.CCR-10-2021 Cianfrocca, 2004, Prognostic and predictive factors in early-stage breast cancer, Oncologist, 9, 606, 10.1634/theoncologist.9-6-606 Warwick, 2004, Time-dependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County Study, Cancer, 1007, 1331, 10.1002/cncr.20140 Donegan, 1997, Tumor-related prognostic factors for breast cancer, CA Cancer J Clin, 47, 28, 10.3322/canjclin.47.1.28 Chagpar, 2011, Lymph node ratio should be considered for incorporation into staging for breast cancer, Ann Surg Oncol, 18, 3143, 10.1245/s10434-011-2012-9 Danko, 2010, Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up, J Am Coll Surg, 210, 797, 10.1016/j.jamcollsurg.2010.02.045 Fisher, 1993, Pathologic findings from the National Surgical Adjuvant Breast Project Protocol B-06: 10-year pathologic and clinical prognostic discriminants, Cancer, 71, 2507, 10.1002/1097-0142(19930415)71:8<2507::AID-CNCR2820710813>3.0.CO;2-0 Heimann, 2000, Clinical progression of breast cancer malignant behavior: what to expect and when to expect it, J Clin Oncol, 18, 591, 10.1200/JCO.2000.18.3.591 Yerushalmi, 2010, Ki67 in breast cancer: prognostic and predictive potential, Lancet Oncol, 11, 174, 10.1016/S1470-2045(09)70262-1 Fasching, 2011, Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment, BMC Cancer, 11, 486, 10.1186/1471-2407-11-486